Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | EIF4E | P06730 | 8/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.35 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14653421 | 0.85 | ALOX5 (0.47) | CRHBPCRHR2TDP1ALDH1A1EIF4E | |
| SCHEMBL26536408 | 0.83 | ALOX5 (0.45) | CRHBPCRHR2TDP1ALDH1A1EIF4E | |
| SCHEMBL17044595 | 0.79 | ALOX5 (0.46) | CRHBPCRHR2ALDH1A1THRBMAPT | |
| SCHEMBL14653392 | 0.78 | ALDH1A1 (0.62) | CRHBPCRHR2TDP1ALDH1A1EIF4E | |
| SCHEMBL17416271 | 0.77 | MAPK1 (0.48) | CRHBPCRHR2ALDH1A1MAPT | |
| SCHEMBL2816974 | 0.77 | CRHBP (0.61) | CRHBPCRHR2TDP1ALDH1A1EIF4E | |
| SCHEMBL15860099 | 0.77 | ALDH1A1 (0.51) | CRHBPCRHR2TDP1ALDH1A1EIF4E | |
| SCHEMBL15791110 | 0.76 | TDP1 (0.53) | CRHBPCRHR2TDP1ALDH1A1MAPT | |
| SCHEMBL11933061 | 0.76 | TDP1 (0.53) | TDP1ALDH1A1MAPT | |
| SCHEMBL26536499 | 0.76 | CRHBP (0.41) | CRHBPCRHR2TDP1ALDH1A1EIF4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9290513-B2 | Compound containing 5-membered heterocycles, organic electronic device using same, and terminal comprising the latter | DUK SAN NEOLUX CO., LTD. (KR) | 2016-03-22 | — | — | US | disclosed |
| US-9290513-B2 | Compound containing 5-membered heterocycles, organic electronic device using same, and terminal comprising the latter | DUK SAN NEOLUX CO., LTD. (KR) | 2016-03-22 | — | — | US | disclosed |
| US-20150307514-A1 | COMPOUND CONTAINING 5-MEMBERED HETEROCYCLES, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL COMPRISING THE LATTER | DUK SAN NEOLUX CO., LTD. (KR) | 2015-10-29 | — | — | US | disclosed |
| US-20150307514-A1 | COMPOUND CONTAINING 5-MEMBERED HETEROCYCLES, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL COMPRISING THE LATTER | DUK SAN NEOLUX CO., LTD. (KR) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150307514-A1 | COMPOUND CONTAINING 5-MEMBERED HETEROCYCLES, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL COMPRISING THE LATTER | EMC2, AOC2, MCM5 | CRHBP 4571/4885CRHR2 4422/4885TDP1 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.